![Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance](https://onlinelibrary.wiley.com/cms/asset/31dfb1a1-b51c-4cde-9d5e-94576bf5c437/jmri.v55.4.cover.jpg?trick=1663369010306)
Intravoxel Incoherent Motion Diffusion‐Weighted Imaging for Predicting and Monitoring the Response of Anti‐Angiogenic Treatment in the Orthotopic Nude Mouse Model of Lung Adenocarcinoma - Wan - 2022 - Journal of Magnetic Resonance
![Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/809428/5915611/gr1.jpg)
Concepts, Considerations, and Concerns on the Cutting Edge of Radiofrequency Ablation - Journal of Vascular and Interventional Radiology
![Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378874120336588-fx1.jpg)
Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy - ScienceDirect
![MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/28d1f47b-5a6e-4ee2-9f76-82a2a67b2c1f/gr4_lrg.jpg)
MET Amplification and Efficacy of Nivolumab in Patients With NSCLC - JTO Clinical and Research Reports
![PDF) Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma PDF) Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma](https://i1.rgstatic.net/publication/347897877_Mechanistic_Modeling_of_Gene_Regulation_and_Metabolism_Identifies_Potential_Targets_for_Hepatocellular_Carcinoma/links/60159e1192851c2d4d068f9f/largepreview.png)
PDF) Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma
![Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4d7780aa-be93-4180-a571-051133037f75/gr1.jpg)
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer - Lung Cancer
![Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2d4d7f76-7799-4e63-a95a-c030b8d47ae2/gr1_lrg.jpg)
Proposal for multiple new lesions as complement of hyperprogressive disease in NSCLC patients treated with PD-1/PD-L1 immunotherapy - Lung Cancer
![Frontiers | Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review Frontiers | Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review](https://www.frontiersin.org/files/Articles/810472/fnut-09-810472-HTML-r1/image_m/fnut-09-810472-g001.jpg)
Frontiers | Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review
![Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC - Lung Cancer Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC - Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ff2a22ac-8683-400f-aa29-db7ba11c55c5/gr1.jpg)
Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC - Lung Cancer
![IJMS | Free Full-Text | If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer | HTML IJMS | Free Full-Text | If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer | HTML](https://www.mdpi.com/ijms/ijms-22-03025/article_deploy/html/images/ijms-22-03025-g001.png)
IJMS | Free Full-Text | If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer | HTML
![Frontiers | Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma Frontiers | Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma](https://www.frontiersin.org/files/Articles/595242/fgene-11-595242-HTML/image_m/fgene-11-595242-g001.jpg)
Frontiers | Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma
![Frontiers | Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma Frontiers | Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma](https://www.frontiersin.org/files/Articles/498258/fonc-10-00777-HTML/image_m/fonc-10-00777-g001.jpg)